$5.64 -0.06 (-1.05%)
11/27/2009 12:45 PM

ZymoGenetics, Inc. (ZGEN)

CAPS Rating: 3 out of 5

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Featured Broker Partners